{"transactions":[{"id":680038,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":16049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying the RSU Award shall vest over 4 years, with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying the RSU Award shall vest over 4 years, with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter."}],"balance_after":230042,"derivative":{"underlying":"Common Stock","underlying_shares":16049},"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680037,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the RSU Award shall vest over 4 years, with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying the RSU Award shall vest over 4 years, with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter."}],"balance_after":134862,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680036,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSU Award shall vest over 4 years, with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSU Award shall vest over 4 years, with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":44249,"derivative":{"underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680035,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5401,"price":4.67,"value":25222.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2026 to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":134693,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680034,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":16049,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":140094,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680033,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4392,"price":4.67,"value":20510.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2026 to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":124045,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680032,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":128437,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680031,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2111,"price":4.67,"value":9858.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2026 to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":115386,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":680030,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:34:02.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":6320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":117497,"source":{"system":"sec-edgar","filing":"0001878824-26-000004","document":"form4-08202026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000004/form4-08202026_080854.xml","form_type":"4"}},{"id":770200,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":10699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter, until fully vested."}],"balance_after":246091,"derivative":{"underlying":"Common Stock","underlying_shares":10699},"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770199,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":147913,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770198,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":50569,"derivative":{"underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770197,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3839,"price":3.55,"value":13628.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":111177,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770196,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":10699,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":115016,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770195,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3122,"price":3.55,"value":11083.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":104317,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770194,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":8700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":107439,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770193,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2268,"price":3.55,"value":8051.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":98739,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":770192,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:48:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":6320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":101007,"source":{"system":"sec-edgar","filing":"0001878824-26-000002","document":"form4-05202026_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000002/form4-05202026_090502.xml","form_type":"4"}},{"id":846435,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":17401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":156613,"derivative":{"underlying":"Common Stock","underlying_shares":17401},"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846434,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":56889,"derivative":{"underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846433,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":256790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting  on March 10, 2027 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting August 18, 2026 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting November 18, 2026 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting  on March 10, 2027 and each March 10 thereafter, until fully vested."}],"balance_after":256790,"derivative":{"underlying":"Common Stock","underlying_shares":256790},"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846432,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":136205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the stock option shall vest over 4 years with 1/48 of the total shares underlying the stock option vesting on April 10, 2026 and each month thereafter until fully vested."}],"balance_after":136205,"derivative":{"exercise_price":4.23,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":136205},"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846431,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7145,"price":4.23,"value":30223.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 10, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":94687,"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846430,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":17401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":101832,"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846429,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2603,"price":4.23,"value":11010.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 10, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":84431,"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":846428,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:37:27.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87034,"source":{"system":"sec-edgar","filing":"0001878824-26-000001","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882426000001/form4-03122026_080323.xml","form_type":"4"}},{"id":992639,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":174014,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":992638,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":false,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":63209,"derivative":{"underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":992637,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4196,"price":5.53,"value":23203.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":80714,"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":992636,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":84910,"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":992635,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2032,"price":5.53,"value":11236.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":71859,"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":992634,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T00:03:31.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":true,"shares":6320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":73891,"source":{"system":"sec-edgar","filing":"0001878824-25-000002","document":"form4-11212025_121127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000187882425000002/form4-11212025_121127.xml","form_type":"4"}},{"id":1060425,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":187065,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1060424,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":69529,"derivative":{"underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1060423,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5084,"price":4.06,"value":20641.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":67571,"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1060422,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":72655,"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1060421,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2462,"price":4.06,"value":9995.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":59604,"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1060420,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:45:21.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":6320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":62066,"source":{"system":"sec-edgar","filing":"0001415889-25-022520","document":"form4-08202025_090817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925022520/form4-08202025_090817.xml","form_type":"4"}},{"id":1125398,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T21:39:17.000Z","date":"2025-06-02","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":2.78,"value":97300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.76 to $2.81, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":55746,"source":{"system":"sec-edgar","filing":"0001415889-25-015442","document":"form4-06032025_090608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925015442/form4-06032025_090608.xml","form_type":"4"}},{"id":1139163,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":200116,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1139162,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":false,"shares":25283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":75849,"derivative":{"underlying":"Common Stock","underlying_shares":25283},"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1139161,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3389,"price":2.69,"value":9116.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 19, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":20746,"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1139160,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":true,"shares":8700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":24135,"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1139159,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":9848,"price":2.69,"value":26491.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 19, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":15435,"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1139158,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:57:08.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":true,"shares":25283,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":25283,"source":{"system":"sec-edgar","filing":"0001415889-25-013984","document":"form4-05212025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925013984/form4-05212025_090504.xml","form_type":"4"}},{"id":1219853,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T22:56:30.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":208816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested."}],"balance_after":208816,"derivative":{"underlying":"Common Stock","underlying_shares":208816},"source":{"system":"sec-edgar","filing":"0001415889-25-007282","document":"form4-03062025_100326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925007282/form4-03062025_100326.xml","form_type":"4"}},{"id":1219852,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-06T22:56:30.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":330882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 4, 2025 and each month thereafter until fully vested."}],"balance_after":330882,"derivative":{"exercise_price":4.31,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":330882},"source":{"system":"sec-edgar","filing":"0001415889-25-007282","document":"form4-03062025_100326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588925007282/form4-03062025_100326.xml","form_type":"4"}},{"id":1516176,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-15T23:19:52.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":101132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter; and 3/48  of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter; and 3/48  of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter."}],"balance_after":101132,"derivative":{"underlying":"Common Stock","underlying_shares":101132},"source":{"system":"sec-edgar","filing":"0001415889-24-013281","document":"form4-05152024_110545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588924013281/form4-05152024_110545.xml","form_type":"4"}},{"id":1516175,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-05-15T23:19:52.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":150602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest over 4 years with 25% of the total shares underlying the option vesting on May 13, 2025 and 1/48th of the total shares subject to the option vesting each month thereafter."}],"balance_after":150602,"derivative":{"exercise_price":6.18,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":150602},"source":{"system":"sec-edgar","filing":"0001415889-24-013281","document":"form4-05152024_110545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000141588924013281/form4-05152024_110545.xml","form_type":"4"}},{"id":1798828,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-08-24T01:05:37.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":false,"shares":20795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":41588,"derivative":{"underlying":"Common Stock","underlying_shares":20795},"source":{"system":"sec-edgar","filing":"0001209191-23-047145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123047145/doc4.xml","form_type":"4"}},{"id":1798827,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-08-24T01:05:37.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":false,"shares":9935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total grant on November 15, 2022, and thereafter 1/16th of the total grant vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as to 1/4th of the total grant on November 15, 2022, and thereafter 1/16th of the total grant vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":89417,"derivative":{"underlying":"Common Stock","underlying_shares":9935},"source":{"system":"sec-edgar","filing":"0001209191-23-047145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123047145/doc4.xml","form_type":"4"}},{"id":1798826,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-24T01:05:37.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":11201,"price":1.49,"value":16689.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs."}],"balance_after":169998,"source":{"system":"sec-edgar","filing":"0001209191-23-047145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123047145/doc4.xml","form_type":"4"}},{"id":1798825,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-24T01:05:37.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":true,"shares":20795,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":181199,"source":{"system":"sec-edgar","filing":"0001209191-23-047145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123047145/doc4.xml","form_type":"4"}},{"id":1798824,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-24T01:05:37.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":true,"shares":9935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":160404,"source":{"system":"sec-edgar","filing":"0001209191-23-047145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123047145/doc4.xml","form_type":"4"}},{"id":1891783,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-05-17T01:29:12.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":false,"shares":20795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":62383,"derivative":{"underlying":"Common Stock","underlying_shares":20795},"source":{"system":"sec-edgar","filing":"0001209191-23-029996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123029996/doc4.xml","form_type":"4"}},{"id":1891782,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-05-17T01:29:12.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":false,"shares":9935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total grant on November 15, 2022, and thereafter 1/16th of the total grant vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as to 1/4th of the total grant on November 15, 2022, and thereafter 1/16th of the total grant vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":99352,"derivative":{"underlying":"Common Stock","underlying_shares":9935},"source":{"system":"sec-edgar","filing":"0001209191-23-029996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123029996/doc4.xml","form_type":"4"}},{"id":1891781,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T01:29:12.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":11198,"price":1.8583,"value":20809.2434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs."}],"balance_after":150469,"source":{"system":"sec-edgar","filing":"0001209191-23-029996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123029996/doc4.xml","form_type":"4"}},{"id":1891780,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T01:29:12.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":true,"shares":20795,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":161667,"source":{"system":"sec-edgar","filing":"0001209191-23-029996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123029996/doc4.xml","form_type":"4"}},{"id":1891779,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T01:29:12.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":true,"shares":9935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":140872,"source":{"system":"sec-edgar","filing":"0001209191-23-029996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123029996/doc4.xml","form_type":"4"}},{"id":1918285,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-18T23:55:45.000Z","date":"2023-01-27","kind":"grant","planned":false,"acquired":true,"shares":83178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four equal quarterly installments on May 15, 2023, August 15, 2023, November 15, 2023, and February 15, 2024, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":83178,"derivative":{"underlying":"Common Stock","underlying_shares":83178},"source":{"system":"sec-edgar","filing":"0001209191-23-024744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123024744/doc4.xml","form_type":"4"}},{"id":2008101,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-02-17T21:54:14.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":9935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":109287,"derivative":{"underlying":"Common Stock","underlying_shares":9935},"source":{"system":"sec-edgar","filing":"0001209191-23-010709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123010709/doc4.xml","form_type":"4"}},{"id":2008100,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:54:14.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":4268,"price":3.619,"value":15445.892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs."}],"balance_after":130937,"source":{"system":"sec-edgar","filing":"0001209191-23-010709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123010709/doc4.xml","form_type":"4"}},{"id":2008099,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:54:14.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":9935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":135205,"source":{"system":"sec-edgar","filing":"0001209191-23-010709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919123010709/doc4.xml","form_type":"4"}},{"id":2086708,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-12-14T22:06:35.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":39740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":119222,"derivative":{"underlying":"Common Stock","underlying_shares":39740},"source":{"system":"sec-edgar","filing":"0001209191-22-061262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122061262/doc4.xml","form_type":"4"}},{"id":2086707,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T22:06:35.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":14470,"price":2.6147,"value":37834.709,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs."}],"balance_after":125270,"source":{"system":"sec-edgar","filing":"0001209191-22-061262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122061262/doc4.xml","form_type":"4"}},{"id":2086706,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T22:06:35.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":39740,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":139740,"source":{"system":"sec-edgar","filing":"0001209191-22-061262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122061262/doc4.xml","form_type":"4"}},{"id":2125905,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-11-03T22:32:56.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":233574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2023, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2023, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":233574,"derivative":{"underlying":"Common Stock","underlying_shares":233574},"source":{"system":"sec-edgar","filing":"0001209191-22-055655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122055655/doc4.xml","form_type":"4"}},{"id":2266021,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2022-05-18T23:05:18.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 20, 2020, and thereafter 2.0833% of the remaining shares vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":1910838,"derivative":{"exercise_price":0.18,"expiration_date":"2030-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-030241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122030241/doc4.xml","form_type":"4"}},{"id":2266020,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-18T23:05:18.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":100000,"price":0.18,"value":18000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-22-030241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122030241/doc4.xml","form_type":"4"}},{"id":2424224,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-01-28T01:16:14.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":158962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 1/4th of the total shares on November 15, 2022, and thereafter 1/16th of the total shares vest quarterly until such time as the RSUs are 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":158962,"derivative":{"underlying":"Common Stock","underlying_shares":158962},"source":{"system":"sec-edgar","filing":"0001209191-22-005281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919122005281/doc4.xml","form_type":"4"}},{"id":2479157,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2021-12-10T01:54:47.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":274998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), by and between JAWS Spitfire Acquisition Corporation, a Cayman Islands exempted company (\"JAWS\"), Spitfire Merger Sub, Inc., a Delaware corporation, and Velo3D, Inc., a Delaware corporation (\"Velo3D\"), the parties effected a business combination transaction (\"Business Combination\") on September 29, 2021. As a result of the Business Combination, Velo3D became a wholly owned subsidiary of JAWS. Velo3D was renamed \"Velo3D US, Inc.\" and JAWS was renamed \"Velo3D, Inc.\" (\"New Velo3D\"). Pursuant to the forfeiture provision in the Business Combination Agreement, the outstanding options of Velo3D were exchanged for comparable options of New Velo3D at the exchange ratio of 0.8149 to 1, subject to the same terms and conditions that applied to the original grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/4 of the total shares on August 20, 2020, and thereafter 2.0833% of the remaining shares vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":274998,"derivative":{"exercise_price":0.18,"expiration_date":"2030-09-22","underlying":"Common Stock","underlying_shares":274998},"source":{"system":"sec-edgar","filing":"0001209191-21-068905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919121068905/doc4.xml","form_type":"4"}},{"id":2479156,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2021-12-10T01:54:47.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":2010838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), by and between JAWS Spitfire Acquisition Corporation, a Cayman Islands exempted company (\"JAWS\"), Spitfire Merger Sub, Inc., a Delaware corporation, and Velo3D, Inc., a Delaware corporation (\"Velo3D\"), the parties effected a business combination transaction (\"Business Combination\") on September 29, 2021. As a result of the Business Combination, Velo3D became a wholly owned subsidiary of JAWS. Velo3D was renamed \"Velo3D US, Inc.\" and JAWS was renamed \"Velo3D, Inc.\" (\"New Velo3D\"). Pursuant to the forfeiture provision in the Business Combination Agreement, the outstanding options of Velo3D were exchanged for comparable options of New Velo3D at the exchange ratio of 0.8149 to 1, subject to the same terms and conditions that applied to the original grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/4 of the total shares on August 20, 2020, and thereafter 2.0833% of the remaining shares vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":2010838,"derivative":{"exercise_price":0.18,"expiration_date":"2030-09-22","underlying":"Common Stock","underlying_shares":2010838},"source":{"system":"sec-edgar","filing":"0001209191-21-068905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919121068905/doc4.xml","form_type":"4"}},{"id":2554646,"issuer":{"id":5750,"kind":"organization","name":"Velo3D, Inc.","symbol":"VELO"},"owners":[{"id":21278,"kind":"person","name":"McCombe William D.","position":1,"cik":"0001878824","reported_name":"McCombe William D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Earnout Rights","published_at":"2021-10-02T01:56:10.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":303084,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the earnout provisions in the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), the Reporting Person is entitled to receive shares of New Velo3D Common Stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the Common Stock equals or exceeds certain thresholds (the \"Earnout Rights\"). Of these Earnout Rights, one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $12.50 for any 20 trading days within any 30-trading day period and one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $15.00 for\nany 20 trading days within any 30-trading day period, in each case, subject to adjustment as provided in the Business Combination Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the earnout provisions in the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), the Reporting Person is entitled to receive shares of New Velo3D Common Stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the Common Stock equals or exceeds certain thresholds (the \"Earnout Rights\"). Of these Earnout Rights, one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $12.50 for any 20 trading days within any 30-trading day period and one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $15.00 for\nany 20 trading days within any 30-trading day period, in each case, subject to adjustment as provided in the Business Combination Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the earnout provisions in the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), the Reporting Person is entitled to receive shares of New Velo3D Common Stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the Common Stock equals or exceeds certain thresholds (the \"Earnout Rights\"). Of these Earnout Rights, one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $12.50 for any 20 trading days within any 30-trading day period and one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $15.00 for\nany 20 trading days within any 30-trading day period, in each case, subject to adjustment as provided in the Business Combination Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Pursuant to the earnout provisions in the Business Combination Agreement, dated March 22, 2021 (the \"Business Combination Agreement\"), the Reporting Person is entitled to receive shares of New Velo3D Common Stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the Common Stock equals or exceeds certain thresholds (the \"Earnout Rights\"). Of these Earnout Rights, one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $12.50 for any 20 trading days within any 30-trading day period and one-half will be issued if the volume-weighted average price of the Common Stock equals or exceeds $15.00 for\nany 20 trading days within any 30-trading day period, in each case, subject to adjustment as provided in the Business Combination Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects Earnout Rights acquired pursuant to the Business Combination. The transactions contemplated by the Business Combination Agreement closed on September 29, 2021."}],"balance_after":303084,"derivative":{"expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":303084},"source":{"system":"sec-edgar","filing":"0001209191-21-058692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878824/000120919121058692/doc4.xml","form_type":"4"}}]}